- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT00241852
Family Approach to Managing Asthma in Early Teens
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
BACKGROUND:
Asthma is a public health problem with its prevalence and morbidity being significant in 11- to 14-year olds, particularly among ethnic minorities. Despite this, little has been done to intervene with this age group. This is surprising considering the success of asthma education programs for younger children. In addition, there are no reports of parenting training to help families manage asthma despite the significant influence parenting strategies have on the management of chronic illnesses.
DESIGN NARRATIVE:
The overall goal of this study is to test the efficacy of a program with two complementary components: (a) a school-based curriculum to empower middle school students to manage their asthma and (b) a parent training curriculum to teach childrearing skills that support the youths' growing autonomy and need to self-manage their disease. The specific aims are: (1) to implement screening to identify 6th - 8th grade students with persistent asthma; and (2) to provide health education and parent training to help children and parents manage asthma more effectively. The student program is based on Coping with Asthma at Home and at School, a successful program developed in Holland. The parent program is an adaptation of Thriving Teens, an effective parent training program developed by the investigators. Participants in this randomized control trial will be 384 children with asthma and their caregivers from 16 New York City public schools serving low-income, ethnic minorities. It is hypothesized that students randomized to the intervention will have, relative to controls, improvements in three primary outcomes: (1) reduced symptom severity; (2) improved quality of life; and (3) better asthma management skills. Also, when compared to controls, intervention students will show improvement in the following secondary outcomes: (4) urgent health care utilization; (5) days with activity restriction; and (6) parent-child interactions. Caregivers and children will complete comprehensive surveys assessing these outcomes at baseline, and immediately and 6- and 12-months after the intervention.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Phase 3
Kontakte und Standorte
Studienorte
-
-
New York
-
New York, New York, Vereinigte Staaten, 10016
- New York University School of Medicine
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria for Youth:
- Prior diagnosis of asthma from a medical provider
- Asthma symptoms an average of 3 times per month during the 12 months prior to study entry OR less frequent symptoms but having 1 or more urgent visits to a doctor/emergency room or hospitalization for asthma during the 12 months prior to study entry
- Use of prescribed asthma medication in the 12 months prior to study entry
Inclusion Criteria for Families:
- Child and participating parent must live together
Exclusion Criteria for Youth:
- Co-morbidity that might affect lung function, such as cystic fibrosis or sickle cell anemia
- Highly specialized developmental or learning needs (e.g., Down's syndrome, mental retardation, severe ADHD)
- Major psychiatric illness
Exclusion Criteria for Families:
- Foster parents and their children
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: Behavioral Intervention: Asthma: It's a Family Affair
Separate student and parent intervention groups.
|
Intervention families will receive a comprehensive program with two complementary components: (1) a school-based intervention to empower middle school students to manage their asthma and (2) parent training to teach their caregivers childrearing skills that support the youth's growing autonomy and need to self-manage their disease.
The student component is comprised of 6, 60 minute group workshops; the caregiver component consists of 5, 90-minute group workshops.
|
Aktiver Komparator: Behavioral Control Group
Students and parents participate in an education only control group
|
Caregivers assigned to the Asthma and Stress Comparator group will receive a single educational workshop focusing on the developmental changes adolescents experience, how these changes may cause stress, and ways to cope with stress.
The children will also participate in a single school-based session on similar topics.
Both caregivers and students will learn basic asthma facts.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
---|---|
Symptom severity
Zeitfenster: baseline, immediate post-intervention and every 2 months thereafter up to and including 12-months post-intervention
|
baseline, immediate post-intervention and every 2 months thereafter up to and including 12-months post-intervention
|
quality of life
Zeitfenster: Baseline, and immediate, 6-months and 12-months post-intervention
|
Baseline, and immediate, 6-months and 12-months post-intervention
|
asthma management skills
Zeitfenster: Baseline, and immediate, 6-months and 12-months post-intervention
|
Baseline, and immediate, 6-months and 12-months post-intervention
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
---|---|
Urgent health care utilization
Zeitfenster: baseline, immediate post-intervention and every 2 months thereafter up to and including 12-months post-intervention
|
baseline, immediate post-intervention and every 2 months thereafter up to and including 12-months post-intervention
|
days with activity restriction
Zeitfenster: baseline, immediate post-intervention and every 2 months thereafter up to and including 12-months post-intervention
|
baseline, immediate post-intervention and every 2 months thereafter up to and including 12-months post-intervention
|
parent-child interactions
Zeitfenster: Baseline, and immediate, 6-months and 12-months post-intervention
|
Baseline, and immediate, 6-months and 12-months post-intervention
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Jean-Marie Bruzzese, PhD, NYU Langone Health
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 333
- R01HL079953 (US NIH Stipendium/Vertrag)
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Lungenkrankheit
-
Hal C CharlesAbgeschlossenKonstriktive Bronchiolitis | Irak-Afganistan War Lung Injury SyndromeVereinigte Staaten
-
Joseph MccuneEunice Kennedy Shriver National Institute of Child Health and Human Development... und andere MitarbeiterBeendetLupus erythematodes, systemisch | Systemische Vaskulitis | Lungenerkrankung mit systemischer Sklerose | Isolierte Angiitis des zentralen Nervensystems | Lung Disease Interstitial DiffusVereinigte Staaten
Klinische Studien zur Asthma: It's a Family Affair!
-
Mayo ClinicAnmeldung auf Einladung
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRekrutierungSolider Krebs | Hämatologische MalignitätVereinigtes Königreich
-
Assistance Publique - Hôpitaux de ParisAbgeschlossenHämophagozytische Lymphohistiozytose (HLH)Frankreich
-
Genzyme, a Sanofi CompanyAktiv, nicht rekrutierendMultiple SklerosePortugal, Truthahn, Italien, Österreich, Belgien, Frankreich, Niederlande, Polen, Russische Föderation, Vereinigtes Königreich
-
Royal Surrey County Hospital NHS Foundation TrustUnbekannt
-
Children's Oncology GroupNational Cancer Institute (NCI)RekrutierungB Akute lymphoblastische Leukämie | Leukämie des zentralen Nervensystems | Hodenleukämie | B Lymphoblastisches Lymphom | Akute Leukämie des gemischten PhänotypsVereinigte Staaten, Kanada, Australien, Puerto Rico, Neuseeland